CareDx to Participate in Wells Fargo Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in a fireside chat at the Wells Fargo Healthcare Conference in Boston, Massachusetts, on September 5, 2025, at 8:00 AM ET.

A live and archived webcast of the presentation will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit www.caredx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250821836143/en/

Investor Relations
Caroline Corner
[email protected]

Source: CareDx, Inc.

You May Also Be Interested In

• Brighthouse Financial Announces Preferred Stock Dividends and Related Depositary Share Distributions
• Supra Human Named to Inc. 5000 for Second Consecutive Year, Ranking No. 276 Nationally
• PTX Metals Demonstrates 97% Copper Recovery from Locked Cycle Test at W2 Copper-Nickel-PGE Project